Short Activated Partial Thromboplastin Times Are Related to Increased Thrombin Generation and an Increased Risk for Thromboembolism

Landi, 1992, Venous thromboembolism in acute stroke: prognostic importance of hypercoagulability, Arch Neurol, 49, 279, 10.1001/archneur.1992.00530270093024

Belliveau, 1980, Extremely shortened activated partial thromboplastin times [letter], JAMA, 243, 2286, 10.1001/jama.1980.03300480012006

Easa, 1978, Coagulation abnormalities associated with localized hemorrhage in the neonate, J Pediatr, 92, 989, 10.1016/S0022-3476(78)80384-9

Aronson, 1977, Generation of the combined prothrombin activation peptide (F1+2) during the clotting of blood and plasma, J Clin Invest, 60, 1410, 10.1172/JCI108902

Rosing, 1988, Meizothrombin, a major product of factor Xa-catalized prothrombin activation, Thromb Haemost, 60, 355

Korte, 1998, Preoperative values of molecular coagulation markers identify patients at low risk for intraoperative haemostatic disorders and excessive blood loss, Clin Chem Lab Med, 36, 235, 10.1515/CCLM.1998.040

White GC II, Marder VJ, Colman RW, et al. Approach to the bleeding patient. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, PA: Lippincott; 1994:1134-1147.

Feinstein DI. Immune coagulation disorders. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, PA: Lippincott; 1994:881-905.

McKenna, 1977, Thromboembolism in patients with abnormally short activated thromboplastin time, Thromb Haemost, 38, 893

Gallus, 1973, Relevance of preoperative and postoperative blood tests to postoperative leg-vein thrombosis, Lancet, 2, 805, 10.1016/S0140-6736(73)90855-6

Maher, 1976, Human coagulation abnormalities during acute exposure to hypobaric hypoxia, J Appl Physiol, 41, 702, 10.1152/jappl.1976.41.5.702

Vogt, 1979, Lack of fibrin formation in exercise-induced activation of coagulation, Am J Physiol, 236, H577

Girolami, 1985, The effect of low-dose estroprogestinic preparations on prothrombin complex factors: no significant increase after an 8-month trial, Blut, 50, 141, 10.1007/BF00320070

Gabazza, 1994, Alteration of coagulation and fibrinolysis systems after multidrug anticancer therapy for lung cancer, Eur J Cancer, 30, 1276, 10.1016/0959-8049(94)90172-4